Nucleobindin-1 (CALNUC) | Q02818 | Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles. Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles. Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles. Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood. 2009 Jul 16;114(3):723-32. doi: 10.1182/blood-2009-02-205930. Epub 2009 Apr 15. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Protein profile of exosomes from trabecular meshwork cells. J Proteomics. 2011 May 16;74(6):796-804. doi: 10.1016/j.jprot.2011.02.024. Epub 2011 Mar 8. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT). Proteomics. 2012 Jan;12(2):329-38. doi: 10.1002/pmic.201100477. Epub 2011 Dec 16. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Characterization and proteomic analysis of ovarian cancer-derived exosomes. J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Characterization of human thymic exosomes. PLoS One. 2013 Jul 2;8(7):e67554. doi: 10.1371/journal.pone.0067554. Print 2013. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients. J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients. J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome. Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701. doi: 10.1016/j.bbrc.2013.12.070. Epub 2014 Jan 14. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic analysis of hypoxia-induced U373MG glioma secretome reveals novel hypoxia-dependent migration factors. Proteomics. 2014 Jun;14(12):1494-502. doi: 10.1002/pmic.201300554. Epub 2014 May 16. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic analysis of hypoxia-induced U373MG glioma secretome reveals novel hypoxia-dependent migration factors. Proteomics. 2014 Jun;14(12):1494-502. doi: 10.1002/pmic.201300554. Epub 2014 May 16. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. J Proteomics. 2014 Jun 25;106:191-204. doi: 10.1016/j.jprot.2014.04.028. Epub 2014 Apr 24. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients. J Proteome Res. 2014 Nov 12. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. Oncotarget. 2015 Mar 12. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15. Proteomics. 2015 Jun 2. doi: 10.1002/pmic.201400610. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Exosomes released by keratinocytes modulate melanocyte pigmentation. Nat Commun. 2015 Jun 24;6:7506. doi: 10.1038/ncomms8506. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Extracellular vesicles are rapidly purified from human plasma by PRotein Organic Solvent PRecipitation (PROSPR). Sci Rep. 2015 Sep 30;5:14664. doi: 10.1038/srep14664. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers. J Proteomics. 2016 Jan 13. pii: S1874-3919(15)30214-1. doi: 10.1016/j.jprot.2015.12.016. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Circular RNAs co-precipitate with extracellular vesicles: a possible mechanism for circRNA clearance. PLoS One. 2016 Feb 5;11(2):e0148407. doi: 10.1371/journal.pone.0148407. eCollection 2016. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | ExtraPEG: a polyethylene glycol-based method for enrichment of extracellular vesicles. Sci Rep. 2016 Apr 12;6:23978. doi: 10.1038/srep23978. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Comparative proteomics of exosomes secreted by tumoral Jurkat T cells and normal human T cell blasts unravels a potential tumorigenic role for valosin-containing protein. Oncotarget. 2016 Apr 11. doi: 10.18632/oncotarget.8678. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Enrichment of extracellular vesicles from tissues of the central nervous system by PROSPR. Mol Neurodegener. 2016 May 23;11(1):41. doi: 10.1186/s13024-016-0108-1. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Effective isolation of exosomes with polyethylene glycol from cell culture supernatant for in-depth proteome profiling. Analyst. 2016 May 27. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Exosomes in the nose induce immune cell trafficking and harbour an altered protein cargo in chronic airway inflammation. J Transl Med. 2016 Jun 20;14(1):181. doi: 10.1186/s12967-016-0927-4. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression. J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression. J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression. J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | AHNAK enables mammary carcinoma cells to produce extracellular vesicles that increase neighboring fibroblast cell motility. Oncotarget. 2016 Jun 27. doi: 10.18632/oncotarget.10307. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials. 2016 Jul 6;105:195-205. doi: 10.1016/j.biomaterials.2016.07.003. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Identification and Characterization of 293T Cell-Derived Exosomes by Profiling the Protein, mRNA and MicroRNA Components. PLoS One. 2016 Sep 20;11(9):e0163043. doi: 10.1371/journal.pone.0163043. eCollection 2016. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic and bioinformatic characterization of extracellular vesicles released from human macrophages upon influenza A virus infection. J Proteome Res. 2016 Oct 11. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Detailed Analysis of Protein Topology of Extracellular Vesicles-Evidence of Unconventional Membrane Protein Orientation. Sci Rep. 2016 Nov 8;6:36338. doi: 10.1038/srep36338. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer. Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer. Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer. Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Characterisation of extracellular vesicle-subsets derived from brain endothelial cells and analysis of their protein cargo modulation after TNF exposure. J Extracell Vesicles. 2017 Apr 19;6(1):1302705. doi: 10.1080/20013078.2017.1302705. eCollection 2017. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Motile hepatocellular carcinoma cells preferentially secret sugar metabolism regulatory proteins via exosomes. Proteomics. 2017 Jun 7. doi: 10.1002/pmic.201700103. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Motile hepatocellular carcinoma cells preferentially secret sugar metabolism regulatory proteins via exosomes. Proteomics. 2017 Jun 7. doi: 10.1002/pmic.201700103. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Multiple extracellular vesicle types in peritoneal dialysis effluent are prominent and contain known biomarkers. PLoS One. 2017 Jun 8;12(6):e0178601. doi: 10.1371/journal.pone.0178601. eCollection 2017. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method. J Extracell Vesicles. 2017 Apr 28;6(1):1313091. doi: 10.1080/20013078.2017.1313091. eCollection 2017. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method. J Extracell Vesicles. 2017 Apr 28;6(1):1313091. doi: 10.1080/20013078.2017.1313091. eCollection 2017. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method. J Extracell Vesicles. 2017 Apr 28;6(1):1313091. doi: 10.1080/20013078.2017.1313091. eCollection 2017. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature. Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature. Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature. Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature. Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature. Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature. Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430. | ENOG410XW7D | 149 / 0 / 149 |
Nucleobindin-1 (CALNUC) | Q02818 | Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature. Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430. | ENOG410XW7D | 149 / 0 / 149 |